http://phys.org/ en-us Phys.org internet news portal provides the latest news on science including: Physics, Nanotechnology, Life Sciences, Space Science, Earth Science, Environment, Health and Medicine. Injectable nanoparticles developed at MIT may someday eliminate the need for patients with Type 1 diabetes to constantly monitor their blood-sugar levels and inject themselves with insulin. http://phys.org/news287911172.html Nanotechnology Thu, 16 May 2013 08:19:44 EST news287911172 A "bionic man" costing one million dollars went on display on Tuesday at Britain's Science Museum, complete with artificial organs, synthetic blood and robot limbs. http://phys.org/news279295654.html Electronics Tue, 05 Feb 2013 14:07:39 EST news279295654 October 4, 2012—Diabetes mellitus is a chronic disease in which individuals exhibit high levels of sugar in the blood, either due to insufficient production of insulin—the hormone that allows glucose to be absorbed by body cells—or the body's lack of response to insulin. Type 1 diabetes occurs due to loss or dysfunction of β-cells of the pancreas, the organ that produces insulin. Type 2 diabetes is caused by a defective glucose-insulin regulatory system. The most common control for diabetes is by subcutaneous injection of insulin analogues through insulin pumps. http://phys.org/news268575771.html Other Sciences Thu, 04 Oct 2012 13:23:05 EST news268575771 (PhysOrg.com) -- Cambridge research funded by the health charity Diabetes UK has for the first time successfully demonstrated the potential of an artificial pancreas in pregnant women with Type 1 diabetes. It is hoped the development could drastically reduce cases of stillbirth and mortality rates among pregnant women with the condition. http://phys.org/news215715687.html Medicine & Health Mon, 31 Jan 2011 17:01:37 EST news215715687 Diabetes experts at a meeting convened by the U.S. Food and Drug Administration (FDA) and the National Institutes of Health (NIH) took the next step in advancing efforts toward the development of an artificial pancreas: putting forth clinical recommendations to ensure the safe and effective testing of artificial pancreas technology in real-life situations. We are pleased at today's meeting there was a strong consensus among leading clinicians, researchers and industry leaders regarding the path toward outpatient studies for both low-glucose suspend and artificial pancreas systems. http://phys.org/news208632973.html Medicine & Health Wed, 10 Nov 2010 18:00:04 EST news208632973 Scientists are getting closer to offering an "artificial pancreas" to children and adults with type 1 diabetes that will help better control the swings of blood glucose that come with the disease. http://phys.org/news196920208.html Medicine & Health Mon, 28 Jun 2010 05:50:01 EST news196920208 An artificial pancreas system that closely mimics the body's blood sugar control mechanism was able to maintain near-normal glucose levels without causing hypoglycemia in a small group of patients. The system, combining a blood glucose monitor and insulin pump technology with software that directs administration of insulin and the blood-sugar-raising hormone glucagon, was developed at Boston University (BU). The first clinical trial of the system was conducted at Massachusetts General Hospital (MGH) and confirmed the feasibility of an approach utilizing doses of both hormones. In their report, appearing in Science Translational Medicine, the researchers also found unexpectedly large differences in insulin absorption rates between study participants, differences they were able to account for by adjustments to the system. http://phys.org/news190468700.html Medicine & Health Wed, 14 Apr 2010 14:00:14 EST news190468700 Use of 'artificial pancreas' closed-loop insulin delivery systems, in which insulin is delivered in response to changing blood sugar levels, can improve blood sugar control in patients with type 1 diabetes. This is the conclusion of an Article published Online First and in an upcoming edition of The Lancet, written by Dr Roman Hovorka, Institute of Metabolic Science, University of Cambridge and Addenbrooke's Hospital, Cambridge, and colleagues. http://phys.org/news184513806.html Medicine & Health Thu, 04 Feb 2010 18:30:07 EST news184513806